Skip to content

MATINAS BIOPHARMA HOLDINGS, INC.: filings

Every MATINAS BIOPHARMA HOLDINGS, INC. annual and quarterly report in the SEC record with the published financial measures it tagged, 51 filings, each linked to its SEC index.

Filings with published measures

Each page shows what one filing reported, as tagged in that filing, with the periods it covered. Later filings can restate a value; the company overview shows the latest-filed value per period.

FormFiledFiscal periodMeasuresFactsSEC accession
10-Q2026-08-13fiscal Q2 202633860001493152-26-037748
10-Q2026-05-08fiscal Q1 202633650001493152-26-022010
10-K2026-03-31fiscal FY 202543830001493152-26-014132
10-Q2025-11-10fiscal Q3 2025361000001493152-25-021506
10-Q2025-08-14fiscal Q2 202536970001641172-25-024014
10-Q2025-05-15fiscal Q1 202536740001641172-25-011026
10-K2025-04-15fiscal FY 202444830001641172-25-004882
10-Q2024-11-13fiscal Q3 2024391050001493152-24-045201
10-Q2024-08-14fiscal Q2 2024391060001493152-24-032144
10-Q2024-05-09fiscal Q1 202438810001493152-24-018417
10-K2024-03-27fiscal FY 202340830001493152-24-011493
10-Q2023-11-08fiscal Q3 2023391070001493152-23-039892
10-Q2023-08-09fiscal Q2 2023391080001493152-23-027340
10-Q2023-05-10fiscal Q1 202338820001493152-23-016151
10-K2023-03-15fiscal FY 202240840001493152-23-007726
10-Q2022-11-02fiscal Q3 2022391050001493152-22-030195
10-Q2022-08-11fiscal Q2 2022401100001493152-22-021955
10-Q2022-05-12fiscal Q1 202239830001493152-22-012915
10-K/A2022-03-11fiscal FY 202138790001493152-22-006614
10-K2022-03-08fiscal FY 202138790001493152-22-006231
10-Q2021-11-08fiscal Q3 2021371030001493152-21-027448
10-Q2021-08-10fiscal Q2 2021381010001493152-21-019096
10-Q2021-05-10fiscal Q1 202136770001493152-21-010827
10-K2021-03-29fiscal FY 202036760001493152-21-006979
10-Q2020-11-06fiscal Q3 202037960001493152-20-020630
10-Q2020-08-10fiscal Q2 202037950001493152-20-015080
10-Q2020-05-11fiscal Q1 202035720001493152-20-008222
10-K2020-03-09fiscal FY 201938770001493152-20-003558
10-Q2019-11-13fiscal Q3 201933870001493152-19-016958
10-Q2019-08-13fiscal Q2 201933910001493152-19-012114
10-Q2019-05-13fiscal Q1 201932670001493152-19-006906
10-K2019-04-01fiscal FY 201832650001493152-19-004560
10-Q2018-11-09fiscal Q3 201831780001493152-18-015591
10-Q2018-08-09fiscal Q2 201832810001493152-18-011293
10-Q2018-05-09fiscal Q1 201830620001493152-18-006484
10-K2018-03-16fiscal FY 201732760001493152-18-003518
10-Q2017-11-14fiscal Q3 201729730001493152-17-013197
10-Q2017-08-08fiscal Q2 201728760001144204-17-040982
10-Q2017-05-15fiscal Q1 201727570001144204-17-027474
10-K2017-03-31fiscal FY 201630640001144204-17-018184
10-Q2016-11-14fiscal Q3 201629770001144204-16-134200
10-Q2016-08-15fiscal Q2 201628730001144204-16-119395
10-Q2016-05-13fiscal Q1 201629610001144204-16-101865
10-K2016-03-30fiscal FY 201529600001144204-16-091635
10-Q2015-11-10fiscal Q3 201526690001144204-15-063966
10-Q2015-08-13fiscal Q2 201525650001144204-15-048999
10-Q2015-05-15fiscal Q1 201526580001144204-15-031549
10-K2015-03-31fiscal FY 201427550001144204-15-019575
10-Q2014-11-14fiscal Q3 201424580001144204-14-068425
10-Q2014-08-08fiscal Q2 201421520001144204-14-048056
10-Q2014-06-06fiscal Q1 201422560001144204-14-036135

Inspect the source

Entity
MATINAS BIOPHARMA HOLDINGS, INC. / CIK 0001582554
Captured
2026-09-20T09:22:54.236Z
SEC response SHA-256
218993fbdcae524fc0c120e888a258d2be15df63a5b4cfc0f198760659dede1e

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001582554.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))